Intelligent Bio Solutions (INBS, Financial) has expanded its range of non-invasive drug testing solutions by introducing the SmarTest Patch. This advanced wearable device, developed by SMARTOX, is designed to detect drugs continuously through sweat for a duration of 7 to 10 days. The SmarTest Patch enhances the company's lineup alongside its core product, the Intelligent Fingerprinting Drug Testing Solution, by offering additional sweat-based, non-invasive testing options.
The SmarTest Patch is discreet, water-resistant, and features tamper-evident technology, making it suitable for extended wear on the skin. It collects sweat to detect various substances such as cocaine, opiates, methamphetamines, marijuana, and fentanyl. By offering different detection windows, INBS can cater to diverse customer needs while maintaining its signature non-invasive approach.
This expansion increases customer flexibility and strengthens Intelligent Bio Solutions' standing as a leader in pain-free drug testing solutions.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Intelligent Bio Solutions Inc (INBS, Financial) is $12.00 with a high estimate of $12.00 and a low estimate of $12.00. The average target implies an upside of 593.64% from the current price of $1.73. More detailed estimate data can be found on the Intelligent Bio Solutions Inc (INBS) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Intelligent Bio Solutions Inc's (INBS, Financial) average brokerage recommendation is currently 1.0, indicating "Buy" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
